DNLI
Denali Therapeutics Inc
21.00$
+2.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +638.9% | +79.6% | +36.0% | -16.4% | +190.0% | -12.5% | +4.0% | -21.0% | +19.1% | -16.7% | |
| – | +444.3% | +125.1% | +17.4% | -10.6% | +247.8% | -40.0% | +52.9% | -22.5% | -18.8% | +4.2% | |
| – | +29.6% | +448.0% | -64.7% | +3.0% | +538.3% | -42.1% | -25.7% | -41.7% | +37.6% | +17.4% | |
| – | +480.1% | +127.8% | +14.3% | -10.5% | +253.8% | -41.1% | +54.4% | -22.6% | -19.5% | +4.3% | |
| – | – | +5.9% | +1,741.8% | – | – | -78.4% | +657.1% | -63.2% | -36.5% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +381.8% | -2.2% | +68.6% | +220.5% | -49.4% | +70.4% | +7.1% | – | – | – | |
| – | -68.4% | +26.5% | +450.2% | +37.5% | +186.6% | -2.6% | -5.4% | -70.6% | +17.5% | -9.3% | |
| – | +161.6% | +55.5% | +131.5% | +38.3% | +58.1% | +427.5% | -3.8% | -78.6% | +31.1% | -3.8% | |
| – | – | – | – | -80.8% | +28.0% | +16.3% | +34.2% | -0.8% | +65.8% | -20.7% | |
| – | +14.6% | +38.4% | -30.4% | +37.0% | -58.6% | +346.2% | -41.6% | +239.9% | +17.4% | -70.1% | |
| – | – | +83.0% | +17.4% | -27.8% | +191.4% | -16.4% | +8.3% | -1.1% | +19.3% | -17.6% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +113.7% | +132.9% | +519.0% | +3.2% | +17.9% | +7.8% | +3.3% | +9.4% | +19.7% | +6.7% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.